MENU
+Compare
TCRT
Stock ticker: NASDAQ
AS OF
Sep 12, 04:57 PM (EDT)
Price
$2.31
Change
-$0.07 (-2.94%)
Capitalization
5.25M

TCRT Alaunos Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy... Show more

Industry: #Biotechnology
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TCRT with price predictions
Sep 11, 2025

TCRT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on August 07, 2025

TCRT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where TCRT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TCRT's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 03, 2025. You may want to consider a long position or call options on TCRT as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TCRT just turned positive on August 28, 2025. Looking at past instances where TCRT's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TCRT advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCRT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TCRT entered a downward trend on September 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TCRT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.434) is normal, around the industry mean (20.431). P/E Ratio (0.000) is within average values for comparable stocks, (53.322). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.177). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (625.000) is also within normal values, averaging (335.915).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TCRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a cancer treatment company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KODK6.000.25
+4.35%
Eastman Kodak Company
XBIO3.100.12
+4.03%
Xenetic Biosciences
CRGY8.800.10
+1.15%
Crescent Energy Company
MCHX1.98-0.02
-1.00%
Marchex
WF55.30-1.17
-2.07%
Woori Financial Group

TCRT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
+8.68%
SNTI - TCRT
47%
Loosely correlated
+6.15%
REVB - TCRT
46%
Loosely correlated
-18.62%
BRTX - TCRT
33%
Loosely correlated
+1.91%
ALNY - TCRT
30%
Poorly correlated
-0.16%
KPRX - TCRT
29%
Poorly correlated
-0.37%
More